NBIX
NEUROCRINE BIOSCIENCES INC
Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer
Total Trades
200
Buys
0
Sells
145
Largest Trade
N/A
Insiders
17
Institutional Funds
622
Inst. Value
$1M+
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Delaet Ingrid | Chief Regulatory O… | SELL | $500K+ | 7K | $135.34 | Mar 1, 2024 |
| BENEVICH ERIC | Chief Commercial O… | EXERCISE | $1M+ | 75K | $53.67 | Feb 29, 2024 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $1M+ | 75K | $134.69 | Feb 29, 2024 |
| Norwalk Leslie V | Director | EXERCISE | $500K+ | 8K | $84.95 | Feb 29, 2024 |
| Norwalk Leslie V | Director | SELL | $1M+ | 8K | $135.67 | Feb 29, 2024 |
| POPS RICHARD F | Director | EXERCISE | $100K–$500K | 15K | $12.98 | Feb 22, 2024 |
| POPS RICHARD F | Director | SELL | $1M+ | 15K | $132.47 | Feb 22, 2024 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $100K–$500K | 1K | $132.96 | Feb 15, 2024 |
| Onyia Jude | Chief Scientific O… | SELL | $100K–$500K | 1K | $132.94 | Feb 15, 2024 |
| Lippoldt Darin | Chief Legal Officer | SELL | $100K–$500K | 1K | $132.99 | Feb 15, 2024 |
| GORMAN KEVIN CHARLES | CEO | SELL | $100K–$500K | 3K | $133.02 | Feb 15, 2024 |
| Gano Kyle | Chief Business Dev… | SELL | $100K–$500K | 1K | $132.89 | Feb 15, 2024 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $50K–$100K | 716 | $133.03 | Feb 15, 2024 |
| Cooke Julie | CHRO | SELL | $100K–$500K | 796 | $133.04 | Feb 15, 2024 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 2K | $133.07 | Feb 15, 2024 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $100K–$500K | 1K | $133.01 | Feb 15, 2024 |
| ABERNETHY MATT | CFO | SELL | $100K–$500K | 1K | $132.85 | Feb 15, 2024 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 2K | $137.09 | Feb 9, 2024 |
| Cooke Julie | CHRO | SELL | $100K–$500K | 3K | $138.61 | Feb 9, 2024 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $100K–$500K | 2K | $138.49 | Feb 9, 2024 |
| Lippoldt Darin | Chief Legal Officer | SELL | $100K–$500K | 2K | $138.47 | Feb 9, 2024 |
| GORMAN KEVIN CHARLES | CEO | SELL | $500K+ | 5K | $138.74 | Feb 9, 2024 |
| Gano Kyle | Chief Business Dev… | SELL | $100K–$500K | 3K | $139.16 | Feb 9, 2024 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $100K–$500K | 2K | $138.68 | Feb 9, 2024 |
| ABERNETHY MATT | CFO | SELL | $100K–$500K | 2K | $138.73 | Feb 9, 2024 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $100K–$500K | 1K | $140.79 | Feb 3, 2024 |
| Onyia Jude | Chief Scientific O… | SELL | $15K–$50K | 126 | $141.94 | Feb 3, 2024 |
| Lippoldt Darin | Chief Legal Officer | SELL | $100K–$500K | 1K | $140.65 | Feb 3, 2024 |
| GORMAN KEVIN CHARLES | CEO | SELL | $100K–$500K | 3K | $140.69 | Feb 3, 2024 |
| Gano Kyle | Chief Business Dev… | SELL | $100K–$500K | 2K | $140.70 | Feb 3, 2024 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $100K–$500K | 1K | $140.65 | Feb 3, 2024 |
| Cooke Julie | CHRO | SELL | $100K–$500K | 2K | $141.29 | Feb 3, 2024 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 2K | $140.80 | Feb 3, 2024 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $100K–$500K | 1K | $140.78 | Feb 3, 2024 |
| ABERNETHY MATT | CFO | SELL | $100K–$500K | 1K | $140.72 | Feb 3, 2024 |
| Lippoldt Darin | Chief Legal Officer | SELL | $1M+ | 10K | $139.86 | Jan 24, 2024 |
| Lippoldt Darin | Chief Legal Officer | EXERCISE | $500K+ | 10K | $79.02 | Jan 24, 2024 |
| Gano Kyle | Chief Business Dev… | EXERCISE | $1M+ | 75K | $19.59 | Jan 4, 2024 |
| Gano Kyle | Chief Business Dev… | SELL | $1M+ | 75K | $131.47 | Jan 4, 2024 |
| RASTETTER WILLIAM H | Director | SELL | $1M+ | 11K | $131.47 | Jan 4, 2024 |
| RASTETTER WILLIAM H | Director | EXERCISE | $100K–$500K | 20K | $12.98 | Jan 4, 2024 |
| ROBERTS EIRY | Chief Medical Offi… | SELL | $1M+ | 10K | $126.74 | Dec 27, 2023 |
| LYONS GARY A | Director | SELL | $1M+ | 10K | $130.04 | Dec 27, 2023 |
| Cooke Julie | CHRO | SELL | $1M+ | 24K | $128.66 | Dec 27, 2023 |
| Cooke Julie | CHRO | EXERCISE | $1M+ | 24K | $73.04 | Dec 27, 2023 |
| Onyia Jude | Chief Scientific O… | SELL | $100K–$500K | 2K | $113.57 | Dec 1, 2023 |
| Lippoldt Darin | Chief Legal Officer | SELL | $1M+ | 11K | $112.27 | Nov 29, 2023 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 1K | $112.68 | Oct 4, 2023 |
| LYONS GARY A | Director | EXERCISE | $50K–$100K | 5K | $12.98 | Sep 14, 2023 |
| LYONS GARY A | Director | SELL | $500K+ | 5K | $115.02 | Sep 14, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 622 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DODGE & COX | 5.5M | $1M+ | SH |
| STATE STREET CORP | 4.2M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.3M | $1M+ | SH |
| NORGES BANK | 1.1M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 851K | $1M+ | SH |
| Pictet Asset Management Holding SA | 777K | $1M+ | SH |
| BRAIDWELL LP | 752K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 634K | $1M+ | SH |
| Swedbank AB | 584K | $1M+ | SH |
| Swedbank AB | 584K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 555K | $1M+ | SH |
| PRIMECAP MANAGEMENT CO/CA/ | 508K | $1M+ | SH |
| IEQ CAPITAL, LLC | 505K | $1M+ | SH |
| FIRST TRUST ADVISORS LP | 487K | $1M+ | SH |
| Zurich Insurance Group Ltd/FI | 459K | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 361K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 331K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 314K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Jan 21, 2026
5.2%
5.2M shares
SC 13G · May 14, 2025
5.6%
5.5M shares
SC 13G/A · Apr 28, 2025
12.1%
12.1M shares
SC 13G/A · Mar 6, 2025
10.2%
10.1M shares
SC 13G · Feb 5, 2025
4.8%
4.9M shares
STATE STREET CORPORATION 04-2456637
SC 13G · Oct 17, 2024
5.1%
5.1M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.9%
9.7M shares
SC 13G/A · Jan 23, 2024
13.9%
13.6M shares
SC 13G/A · Jan 23, 2023
13.1%
12.6M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
4.5%
4.4M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2022
7.8%
7.4M shares
SC 13G/A · Jan 27, 2022
12.1%
11.5M shares
SC 13G/A · Jan 25, 2022
12.1%
11.5M shares